Skip to main content
Springer Nature Link
Log in

Effects of β-endorphin, met-enkephalm, and dynorphin a on basal and stimulated insulin secretion in the mouse

  • Review
  • Published:
International journal of pancreatology Aims and scope Submit manuscript

Summary

Since opioid peptides and opiate receptors have been demonstrated in the pancreatic islets, we investigated the effects of β-endorphin, metenkephalin, and dynorphin A, on basal and stimulated insulin secretion in the mouse. Each of the three opioid peptides was injected intravenously (0.06-64 nmol/kg) alone or together with each of the three insulin releasing agents glucose (2.8 mmol/kg), carbachol (cholinergic agonist, 0.16 µmol/kg), or terbutaline (β2-adrenoceptor agonist, 3.6 µmol/kg). It was found that β-endorphin, met-enkephalin, and dynorphin A were all without effect on basal plasma insulin levels, except a slight elevation by β -endorphin induced at 2 min after its injection at 64 nmol/kg (to 41 ±2 µU/mL vs 28±4 µU/mL in controls; p<0.05). Glucose- and terbutaline-induced insulin secretion were inhibited by µ-endorphin at the lower dose levels of 0.25 (p<0.01) and 1 nmol/kg (p<0.05). This effect was counteracted by the opiate receptor antagonist naloxone (500 µg/kg). In contrast, β-endorphin at the high dose levels of 16 and 64 nmol/kg augmented the glucose- and terbutaline-induced insulin secretion (p<0.05). Carbacholinduced insulin secretion was not affected by β-endorphin at the lower dose levels but augmented by the peptide at 64 nmol/kg (p<0.01). Metenkephalin inhibited glucose- (p<0.01) and terbutaline- (p<0.05) induced insulin secretion at the high dose rates of 16 and 64 nmol/kg, but the peptide was without effect on carbachol-induced insulin secretion. The inhibitory effects were counteracted by naloxone. Dynorphin A did not affect stimulated insulin secretion at any of the dose levels tested. In summary, in the mouse

  1. 1.

    β-Endorphin at low dose levels inhibits and at high dose levels augments stimulated insulin secretion;

  2. 2.

    Met-enkephalin inhibits stimulated insulin secretion; and

  3. 3.

    Dynorphin A does not affect insulin secretion.

It is suggested that the main influence of β-endorphin and met-enkephalin under in vivo conditions in the mouse is to inhibit stimulated insulin secretion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Roussier J. Opioid peptides have found their roots. Nature 1982; 298: 221–222.

    Article  Google Scholar 

  2. Noda M, Teranishi Y, Takahashi H, Furatani Y, Hirose T, Inayama S, Nakanishi S, Numa S. Isolation and structural organisation of the human preproenkephalm gene. Nature 1982; 297: 431–434.

    Article  PubMed  CAS  Google Scholar 

  3. Kadikani H, Furatani Y, Takahoshi H, Noda M, Morimoto Y, Hirose T, Asai M, Inayama S, Nakanishi S, Numa S. Cloning and sequence analysis of cDNA for porcine B-neo-endorphin-dynorphin precursor. Nature 1982; 298: 245–249.

    Article  Google Scholar 

  4. Giugliano D, Torella R, Lefebvre, PJ, D’Onofrio F. Opioid peptides and metabolic regulation. Diabetologia 1988; 31: 3–15.

    PubMed  CAS  Google Scholar 

  5. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. Endogenous opioids: Biology and function. Ann. Rev. Neurosci. 1984; 7: 223–255.

    Article  PubMed  CAS  Google Scholar 

  6. Smyth DG. β-Endorphin and related peptides in pituitary, brain, pancreas, and antrum. Br. Med. Bull. 1983; 39: 25–30.

    PubMed  CAS  Google Scholar 

  7. Houck JC, Chang CM, Kimball CD. Pancreatic beta-endorphin-like polypeptides. Pharmacology 1981; 23: 14–23.

    Article  PubMed  CAS  Google Scholar 

  8. Bruni JF, Watkins WB, Yen SSC. B-endorphin in the human pancreas. J. Clin. Endocrinol. Metab. 1979; 49: 649–661.

    PubMed  CAS  Google Scholar 

  9. Feurle GE, Weber U, Helmstaedter V. B-lipotropin-like material in human pancreas and pyloric antral mucosa. Life Sci. 1980; 27: 467–473.

    Article  PubMed  CAS  Google Scholar 

  10. Feurle GE, Helmstaedter V, Weber V. Met- and leu-enkephalin immuno- and bioreactivity in human stomach and pancreas. Life Sci. 1982; 31: 2961–2969.

    Article  PubMed  CAS  Google Scholar 

  11. Stern AS, Wurzbuger RJ, Barkey R, Spector S. Opioid polypeptides in guinea pig pancreas. Proc. Natl. Acad. Sci. USA 1982; 79: 6703–6706.

    Article  PubMed  CAS  Google Scholar 

  12. Grube D, Voigt KH, Weber E. Pancreatic glucagon cells contain endorphin-like immuno- reactivity. Histochemistry 1978; 59: 75–79.

    Article  PubMed  CAS  Google Scholar 

  13. Watkins WB, Bruni JF, Yen SSC. B-endorphin and somatostatin in the pancreatic D-cell colocalization by immunocytochemistry. J. Histochem. Cytochem. 1980; 28: 1170–1174.

    PubMed  CAS  Google Scholar 

  14. Timmers KI, Voyles NR, King C, Wells M, Fairtile R, Recant L. Opioid peptides in rat islets of Langerhans. Immunoreactive met- and leu-enkephalins and BAM-22P. Diabetes 1986; 35: 52–57.

    Article  PubMed  CAS  Google Scholar 

  15. Cetin Y. Immunohistochemistry of β-neoendorphin and dynorphin in the endocrine pancreas of rat and man. Histochemistry 1985; 83: 369–373.

    Article  PubMed  CAS  Google Scholar 

  16. Cetin Y. Enterochromaffin (EC)- cells of the mammalian gastro-entero-pancreatic (GEP) endocrine system: cellular source of pro-dynorphin-derived peptides. Cell Tissue Res. 1988; 253: 173–179.

    Article  PubMed  CAS  Google Scholar 

  17. Larsson LI. Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal peptide and gastrin/CCK immunoreactive nerves. J. Histochem. Cytochem. 1979; 27: 1283–1284.

    PubMed  CAS  Google Scholar 

  18. Verspohl EJ, Berger U, Ammon HPT. The significance of µ- and δ-receptors in rat pancreatic islets for the opioid-mediated insulin release. Biochem. Biophys. Acta 1986; 888: 217–224.

    Article  PubMed  CAS  Google Scholar 

  19. Khawaja X, Titheradge M, Green IC. Opiate receptor binding sites in rat islets of Langerhans and liver membranes. Diabet. Med. 1987; 4: 387.

    Google Scholar 

  20. Zukin RS, Zukin SR. Multiple opiate receptors: emerging concepts. Life Sci. 1981; 29: 2681–2690.

    Article  PubMed  CAS  Google Scholar 

  21. Wuster M, Schulz R, Herz A. Specificity of opioids towards the mu-, delta- and epsilon-opiate receptors. Neurosci. Lett. 1979; 15: 193–198.

    Article  PubMed  CAS  Google Scholar 

  22. Wolozon BL, Pasternak GW. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA 1981; 78: 6181–6185.

    Article  Google Scholar 

  23. Paterson SJ, Robson LE, Kosterlitz HW. Classification of opioid receptors. Br. Med. Bull. 1983; 39: 31–36.

    PubMed  CAS  Google Scholar 

  24. Knudtzon J. Effects of proopiomelanocortin-derived peptides on plasma levels of glucagon, insulin and glucose. Horm. Metab. Res. 1986; 18: 579–583.

    Article  PubMed  CAS  Google Scholar 

  25. Ehrenreich H, Goebel FD. The role of opioids in the endocrine function of the pancreas. Diab. Res. 1986; 3: 59–66.

    CAS  Google Scholar 

  26. Lala A, Bouloux P, Tamburrano G, Gale E. Opioid peptides and glucose metabolism. J. Endocrinol, invest. 1987; 10: 95–104.

    CAS  Google Scholar 

  27. Ahrén B, Lundquist I. Effects of naloxone on basal and stimulated insulin secretion in the mouse. Eur. J. Pharmacol. 1984; 102: 135–139.

    Article  PubMed  Google Scholar 

  28. Reid RL, Sandler JA, Yen SSC. β-Endorphin stimulates the secretion of insulin and glucagon in humans. J. Clin. Endocrinol. Metab. 1981; 52: 592–594.

    PubMed  CAS  Google Scholar 

  29. Feldman M, Kisel RS, Unger RH, Li CH. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings. N. Engl. J. Med. 1983; 308: 349–353.

    PubMed  CAS  Google Scholar 

  30. Paolisso G, Giugliano D, Scheen AJ, Franchimont P, D’Onofrio F, Lefébvre PJ. Primary role of glucagon release in the effect of β-endorphin on glucose homeostasis in normal man. Acta Endocrinol. 1987; 115: 161–169.

    PubMed  CAS  Google Scholar 

  31. Giugliano D, Cozzolino D, Salvatore T, Ceriello A, Torella R. Dual effect of beta-en- dorphin on insulin secretion in man. Horm. Metab. Res. 1987; 19: 502–503.

    Article  PubMed  CAS  Google Scholar 

  32. Matsumura M, Fukushima T, Saito H, Saito S. In vivo and in vitro effects of β-endorphin on glucose metabolism in the rat. Horm. Metab. Res. 1984; 16: 27–31.

    Article  PubMed  CAS  Google Scholar 

  33. Schleicher RL, Chawla RK, Coan PA, Martino-Saltzman D, Collins DC. β-Endorphin- induced hyperglycemia in rabbits: effects of a glucose or arginine challenge. Am, J. Physiol. 1987; 252: E255-E259.

    CAS  Google Scholar 

  34. Knudtzon J. Hyperinsulinaemic and hyperglycaemic effects of beta-endorphin in rabbits. Horm. Metab. Res. 1986; 18: 505–509.

    Article  PubMed  CAS  Google Scholar 

  35. Rudman D, Berny CJ, Riedeburg CH, Hollins BM, Kutner MH, Lynn MJ, Chawla RK. Effects of opioid peptides and opiate alkaloids on insulin secretion in the rabbit. Endo- crinology 1983; 112: 1702–1710.

    CAS  Google Scholar 

  36. Hart IC, Cowie AT. Effect of morphine, naloxone, and an enkephalin analogue on plasma prolactin, growth hormone, insulin and thyroxine in goats. J. Endocrinol. 1978; 77: 16–17.

    Article  Google Scholar 

  37. Giugliano D, Quatrano A, Consoli G, Ceriello A, Torella R, D’Onofrio F. Inhibitory effect of enkephalin on insulin secretion in healthy subjects and in non-insulin-dependent, diabetic subjects. Metabolism 1987; 36: 286–289.

    Article  PubMed  CAS  Google Scholar 

  38. Jeanrenaud X, Maeder E, Del Pozo E, Felber JP. Effect of an enkephalin analogue (FK 33-824) on glucose tolerance in man. Acta Endocrinol. 1983; 104: 85–90.

    PubMed  CAS  Google Scholar 

  39. Celotti F, Farina JMS, Motta M, Martini L. Effect of met-enkephalin on portal insulin and glucose in the rat. Horm. Metab. Res. 1980; 12: 125–126.

    Article  PubMed  CAS  Google Scholar 

  40. Ahrén B, Lundquist I. Effects of selective and non-selective β-adrenergic agents on insulin secretion in vivo. Eur. J. Pharmacol. 1981; 71: 93–104.

    Article  PubMed  Google Scholar 

  41. Heding LG. A simplified insulin radioimmunoassay method.In: Donato L, Sirchis J, Milhaud G. Labelled Proteins in Tracer Studies. 1966; Euratom, Brussels, pp. 345–350.

    Google Scholar 

  42. Bruss ML, Black AL. Enzymatic microdetermination of glycogen. Anal. Biochem. 1978; 84: 309–312.

    Article  PubMed  CAS  Google Scholar 

  43. Giugliano D, Ceriello A, Di Pinto P, Saccomanno F, Gentile S, Cacciapuoti F. Impaired insulin secretion in human diabetes mellitus. The effect of naloxone-induced opiate receptor blockade. Diabetes 1982; 31: 367–370.

    Article  PubMed  CAS  Google Scholar 

  44. Morley JE. The endocrinology of the opiates and opioid peptides. Metabolism 1981; 30: 195–208.

    Article  PubMed  CAS  Google Scholar 

  45. El-Tayeb KMA, Vranic M, Brubaker PL, Lickley HLA. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs. Diabetologia 1987; 30: 745–754.

    Article  PubMed  CAS  Google Scholar 

  46. Schleicher RL. The effect of β-endorphin (BE) on glucose-stimulated insulin secretion from isolated rabbit pancreatic islets. Proc. 70th Ann. Meet. Endocr. Soc. Proc. 1988; p. 339.

  47. Ipp E, Dobbs R, Unger RH. Morphine and β-endorphin influence the secretion of the endocrine pancreas. Nature 1978; 276: 190–191.

    Article  PubMed  CAS  Google Scholar 

  48. Curry DL, Bennett LL, Li CH. Stimulation of insulin secretion by beta-endorphin (1–27 & 1–31). Life. Sci. 1987; 40: 2053–2058.

    Article  PubMed  CAS  Google Scholar 

  49. Ahrén B, Lundquist I. Effects of α- and β-adrenoceptor stimulation on45Ca+ + efflux and insulin secretion from perfused rat islets. Acta. Physiol. Scand. 1985; 124: 381–389.

    PubMed  Google Scholar 

  50. Ahrén B, Schersteén B. β2-Adrenoceptor induced increase of plasma insulin levels in man: Evidence of direct and indirect B-cell stimulation and liver effects. Diab. Res. 1986; 3: 443–445.

    Google Scholar 

  51. Ahrén B, Lundquist I. α-Adrenoceptor blockade by phentolamine inhibits β-adrenergi- cally and cholinergically induced glucagon secretion in the mouse. Horm. Metab. Res. 1987; 19: 600–604.

    Article  PubMed  Google Scholar 

  52. Green IC, Perrin D, Pedley KC, Leslie RDG, Pyke DA. Effects of enkephalins and morphine on insulin secretion from isolated rat islets. Diabetologia 1980; 19: 158–161.

    Article  PubMed  CAS  Google Scholar 

  53. Toyota T, Ishizuka J, Nagaoka J, Goto Y. Effects of met-enkephalin and dynorphin (1–17) on the secretion of insulin and glucagon from the isolated perfused pancreas. In: Sakamoto N, Min HK, Baba S (eds.) Current Topics in Clinical and Experimental Aspects of Diabetes Mellitus. 1985; Elsevier, Amsterdam, pp. 86–90.

    Google Scholar 

  54. Hermansen K. Enkephalins and the secretion of pancreatic somatostatin and insulin in the dog: studies in vitro. Endocrinology 1983; 113: 1149–1154.

    PubMed  CAS  Google Scholar 

  55. Bailey CJ, Flatt PR. Increased responsiveness to glucoregulatory effect of opiates in obese diabetic ob/ob mice. Diabetologia 1987; 30: 33–37.

    Article  PubMed  CAS  Google Scholar 

  56. Simonds WF. The molecular basis of opioid receptor function. Endocr. Rev. 1988; 9: 200–212.

    PubMed  CAS  Google Scholar 

  57. Klee WA, Koski G, Tocque Simonds WF. On the mechanism of receptor-mediated inhibition of adenylate cyclase. Adv. Cyclic Nucleot. Prot. Phosph. Rec. 1984; 17: 153–159.

    CAS  Google Scholar 

  58. Hescheler J, Rosenthal W, Trautwein W, Schultz G. The GTP-binding protein, Go, regulates neuronal calcium channels. Nature 1987; 325: 445–447.

    Article  PubMed  CAS  Google Scholar 

  59. Prentki M, Matschinsky FM. Ca2 +, cAMP, and phospholipid-derived messengers in coupling mechanisms of insulin secretion. Physiol. Rev. 1987; 67: 1185–1248.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Lund University, Solvegatan 10, S-223 62, Lund, Sweden

    Bo Ahrén

Authors
  1. Bo Ahrén
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahrén, B. Effects of β-endorphin, met-enkephalm, and dynorphin a on basal and stimulated insulin secretion in the mouse. Int J Pancreatol 5, 165–178 (1989). https://doi.org/10.1007/BF02924417

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02924417

Key Words